Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.
Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision notice updated to Revision: v3.3.3. The HHS Vulnerability Disclosure link and the old Revision: v3.3.2 notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the ClinicalTrials.gov page. The core study details remain unchanged.SummaryDifference0.0%
- Check42 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check49 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page.SummaryDifference0.3%
- Check63 days agoChange DetectedOnly minor UI/layout adjustments to headers and page structure are evident, with no substantive changes to study details (title, purpose, endpoints, eligibility criteria, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check92 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference3%
Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.